knowledge -WSS

knowledge

author：comprehensive 2025-09-30 23:20:04 - browse：2

Sage Therapeutics, a biotech developing an experimental treatment for postpartum depression, this week trumpeted strong results from a clinical trial, which cheered investors and pushed up its stock price. But outside the lab, the company’s aggressive efforts to raise awareness of postpartum depression have proved divisive.

The campaign’s message: “When it comes to postpartum depression, silence sucks.” It features close-up photos of distressed, tearful women who can’t speak — because they have pacifiers stuck in their mouths.

The images have been plastered on bus stops, buses, conference booths, and on a dedicated website. The ads don’t specifically mention Sage’s drug, which still needs further testing before the company can bring it to the Food and Drug Administration for possible approval. Instead, they urge women to talk “openly and honestly” about postpartum depression. An estimated 600,000 women in the U.S. alone experience symptoms, which range from insomnia and irritability to difficulty bonding with their baby.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： What does generative AI mean for health care? We asked experts
Next article： Pandemic and All Hazards Preparedness Act needs lean update

focus

entertainment

WSS

Presidential fundraising highlights so far: Trump brings in more than DeSantis

Readout LOUD podcast, live from the STAT Breakthrough Summit East

Medicare Advantage insurers pressure Biden for bigger payments

Novo Nordisk to buy Cardior, building up pipeline of heart drugs

Presidential fundraising highlights so far: Trump brings in more than DeSantis

Biotech investment managers search for lucrative opportunities

leisure time

knowledge

leisure time

Virginia high school admissions case could be legal follow

6 surprising facts about sugar

Drug repurposing or repositioning? The language matters

Mirador, a new biotech startup, launches with $400 million

Dobbs anniversary: the lost opportunity of abortion as health care

Eisai exec who led development of Alzheimer’s drug to retire

The high cost of giving birth even with insurance

See Ryan Reynolds, Hugh Jackman suited up in 1st look at 'Deadpool 3': Photo

In age of alternative facts, a scholarly course on calling out crap

The aspartame in Diet Coke probably isn’t giving you cancer

entertainment

Recent heat wave in the Mediterranean caused by climate change: Study

Novo Nordisk to buy Cardior, building up pipeline of heart drugs

The U.S. needs a new definition of substance use “recovery”

With Wegovy coverage, Medicare patients may face high costs

This gene therapy has record $4.25 million price. It's saved children.

Mirador, a new biotech startup, launches with $400 million

focus

entertainment

entertainment

entertainment